Sunday, April 27, 2025

India’s first intranasal vaccine for COVID gets DCGI approval

Date:

Share post:

New Delhi, Sep 6:  India’s first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation.

Announcing the achievements, Union Health Minister Mansukh Mandaviya termed it a ‘big boost to India’s fight against Covid-19.

“Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation,” Mandaviya tweeted.

In the subsequent tweet he said, “This step will further strengthen our collective fight against the pandemic.

“India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19”, he said.

IANS

Related articles

SC to hear on Monday PIL seeking release of elderly, terminally ill convicted prisoners

New Delhi, April 27 :The Supreme Court is slated to hear on Monday a public interest litigation (PIL)...

‘Mann Ki Baat’: PM Modi describes significance of April-May in India’s freedom struggle

New Delhi, April 27 : Prime Minister Narendra Modi on Sunday reflected on the significance of the months...

Punjab Police bust weapon-smuggling module with Pakistan links

Chandigarh, April 27: Punjab Police on Sunday said they have busted a weapon-smuggling module with links to Pakistan...

CPI(M) expels 3-time MP for objectionable behavior towards woman colleague

Kolkata, April 27: The CPI(M) in West Bengal has expelled three-time Lok Sabha member, Bansa Gopal Chowdhury, from...